Cargando…
Patient Attributes Associated With Better Long-Term Outcomes on Palliative Milrinone
Milrinone is a phosphodiesterase three inhibitor used as an inotrope in patients with advanced heart failure with reduced ejection fraction (HFrEF). Its action is independent of β-receptor stimulation, which makes it preferable in patients who are on β blockers as part of a guideline-directed neuroh...
Autores principales: | Sharma, Toishi, Balakumaran, Kathir, Tandon, Varun, Shah, Nihar, Arora, Sabeena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273353/ https://www.ncbi.nlm.nih.gov/pubmed/32523836 http://dx.doi.org/10.7759/cureus.7979 |
Ejemplares similares
-
Hypertensive Crisis in Cardiac Tamponade
por: Iorgoveanu, Corina, et al.
Publicado: (2018) -
Prosthetic Tricuspid Valve Thrombosis
por: Zaghloul, Ahmed, et al.
Publicado: (2018) -
Revival of Brock's Operation for Intermediary Palliation of Fallot's Tetralogy in Children Anatomically Unsuitable for One-Stage Total Correction of the Anomaly: Interim Results of Two Cases
por: Bhende, Vishal V, et al.
Publicado: (2023) -
Prevalence of Sensorineural Hearing Loss in Children with Palliated or Repaired Congenital Heart Disease
por: Gopineti, Lalitha, et al.
Publicado: (2020) -
Transcatheter Palliation of a Young Infant With Obstructed Supracardiac Total Anomalous Pulmonary Venous Connection
por: Sultan, Mehboob, et al.
Publicado: (2022)